Ticker Details
Immunocore Holdings
IPO Date:	February 5, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.02 | 2.45%
Avg Daily Range (30 D):	$0.65 | 1.82%
Avg Daily Range (90 D):	$0.67 | 1.91%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.3M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	73
Avg Trade Size (Sh.) (30 D):	81
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	1,821
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$1.12M
Avg Institutional Trade (90 D):	$1.59M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.56M
Avg Closing Trade (30 D):	$.91M
Avg Closing Trade (90 D):	$1.78M
Avg Closing Volume:	35.45K

News

Nov 7, 2025 @ 1:00 PM Immunocore presents Phase 1 data for hepatitis B c... Source: Immunocore Holdings Plc

Oct 30, 2025 @ 3:15 PM Growth Picks: 3 Low-Cost Stocks That Could Double ... Source: Chris Markoch

Aug 7, 2025 @ 3:54 PM Immunocore (IMCR) Q2 Revenue Jumps 30% Source: Jesterai

Mar 10, 2025 @ 7:00 PM Immunocore presents initial multiple ascending dos... Source: N/A

Mar 6, 2025 @ 6:00 PM TCR Therapy Clinical Trial Pipeline Accelerates as... Source: Delveinsight

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.58	$	$-.2
Diluted EPS	$-.58	$	$-.2
Revenue	$379.59M	$103.69M	$97.96M
Gross Profit	$376.88M	$103.18M	$96.92M
Net Income / Loss	$-29.23M	$-.18M	$-10.3M
Operating Income / Loss	$-45.11M	$-7.17M	$-14.88M
Cost of Revenue	$2.71M	$.51M	$1.04M
Net Cash Flow	$-39.35M	$10.48M	$11.09M
PE Ratio